TrialDoor helps pancreatic cancer and colorectal cancer patients and their physicians evaluate potential clinical trials the way an oncologist would, examining each trial in detail with a focus on effectively matching each patient to the most appropriate trial. Using two separate engines (one for pancreatic and one for colorectal) every U.S. trial in the NIH clinicaltrials.gov database appropriate for either pancreatic or colorectal cancer are separately scored daily across 15 clinical dimensions using TrialDoor’s proprietary, diagnosis-specific AI assisted rubric refined over thousands of human-reviewed iterations.